The authors showed that METRNL exposure induces bioenergetic failure of T cells and causes CD8+ T cells to become hypofunctional, and METRNL downregulation improves the anti-tumor function of these CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.